Concepedia

Publication | Open Access

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

DOIFull Paper Access

64

Citations

27

References

2021

Year

Antje Wick, Oliver Bähr, Martin Schüler, Kristoffer Staal Rohrberg, Sant P. Chawla, Filip Jankú, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz‐Josef Lenz,
Clinical Cancer Research

Abstract

BAY1436032 was well tolerated and showed evidence of target inhibition and durable objective responses in a small subset of subjects with LGG.

References

YearCitations

Page 1